Dexamethasone 1.5 mg NDC 82804-059

NDC codes

FDA NDC Directory

Product NDC (as listed)82804-059Labeler and product segments. Claims need a package NDC.

Product NDC at billing width82804-0059Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
82804-059-21	82804005921	21 TABLET in 1 DOSE PACK (82804-059-21)Marketed from Jan 18, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dexamethasone 1.5 mgSuffix: 1.5 mg
Generic name (nonproprietary): dexamethasone 1.5 mg
Active ingredients: Dexamethasone — 1.5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Proficient Rx LP
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 201270
Marketing start: Sep 1, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 82804-059_42db0356-3948-444c-bda3-1226b4ca8985SPL ID 42db0356-3948-444c-bda3-1226b4ca8985SPL set ID 42db0356-3948-444c-bda3-1226b4ca8985RxCUI 197580, 846192UNII 7S5I7G3JQLUPC 0382804059218
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N482804005921 followed by a unit qualifier and the quantity

Package 82804-0059-21. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 1, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Allergic States: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, and serum sickness. Dermatologic Diseases: Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, and severe erythema multiforme (Stevens-Johnson syndrome). Endocrine Disorders: Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; may be used in conjunction with synthetic mineralocorticoid analogs where applicable; in infancy mineralocort…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 201270

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 201270
Product	Strength	Form · route	Labeler	Product NDC
Dexamethasone	Dexamethasone 1.5 mg/1	TabletOral	Proficient Rx LP	82804-132
Dexamethasone 1.5 mg	Dexamethasone 1.5 mg/1	TabletOral	Larken Laboratories, Inc.	68047-702
Dexamethasone 1.5 mg	Dexamethasone 1.5 mg/1	TabletOral	Larken Laboratories, Inc.	68047-702
Dexamethasone	Dexamethasone 1.5 mg/1	TabletOral	Advanced Rx Pharmacy of Tennessee, LLC	80425-0346